The Staff Investigator Position of this application was assembled with the specific intention to formalize and expand the activities of an important Huntsman Cancer Institute (HCI) investigator. Dr. Lisa Cannon- Albright. A summary of Dr. Cannon-Albright's qualifications and activities is provided below. The activities proposed contribute specifically to our Cancer Center goal of maximizing achievement in individualized oncology. Dr. Cannon-Albright extensively utilizes our unique resource, the Utah Population Database (UPDB), the only database of its kind in the United States and one of few such resources in the worid. This is a rich source of information for genetic, epidemiological, demographic, and public health studies. Such discoveries have implications for translation regarding individualized cancer susceptibility testing and appropriate surveillance; individual cancer treatment responses for planning optimal therapies; and, identification of targets of intervention for suggesting novel therapies tailored to the individual. Through cancer susceptibility chromosomal loci and gene identification, the Staff Investigator will initiate translational and transdisciplinary investigations characterized by the following: 1) Cooperation between high-risk cancer populations and clinicians focused on prevention and patient care. 2) Development of preclinical models of disease through interactions among clinical trial researchers 3) Interactions between basic scientists interested in genomics and signaling pathways and investigators focused on high-risk populations and clinical trial development. 4) Collaborations among genetic epidemiologists, basic scientists, and clinical prevention specialists.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
3P30CA042014-23S1
Application #
8533382
Study Section
Subcommittee G - Education (NCI)
Project Start
Project End
Budget Start
2012-05-01
Budget End
2013-04-30
Support Year
23
Fiscal Year
2012
Total Cost
$3,410
Indirect Cost
$1,129
Name
University of Utah
Department
Type
DUNS #
009095365
City
Salt Lake City
State
UT
Country
United States
Zip Code
84112
Ou, Judy Y; Fowler, Brynn; Ding, Qian et al. (2018) A statewide investigation of geographic lung cancer incidence patterns and radon exposure in a low-smoking population. BMC Cancer 18:115
Liang, Wenjie; Yang, Pengfei; Huang, Rui et al. (2018) A Combined Nomogram Model to Preoperatively Predict Histologic Grade in Pancreatic Neuroendocrine Tumors. Clin Cancer Res :
Vázquez-Arreguín, Karina; Maddox, Jessica; Kang, Jinsuk et al. (2018) BRCA1 through Its E3 Ligase Activity Regulates the Transcription Factor Oct1 and Carbohydrate Metabolism. Mol Cancer Res 16:439-452
Peres, Lauren C; Cushing-Haugen, Kara L; Anglesio, Michael et al. (2018) Histotype classification of ovarian carcinoma: A comparison of approaches. Gynecol Oncol 151:53-60
Zeng, Tao; Fleming, Aaron M; Ding, Yun et al. (2018) Nanopore Analysis of the 5-Guanidinohydantoin to Iminoallantoin Isomerization in Duplex DNA. J Org Chem 83:3973-3978
Himbert, Caroline; Ose, Jennifer; Nattenmüller, Johanna et al. (2018) Body fatness, adipose tissue compartments and biomarkers of inflammation and angiogenesis in colorectal cancer: the ColoCare Study. Cancer Epidemiol Biomarkers Prev :
Madison, Bethany J; Clark, Kathleen A; Bhachech, Niraja et al. (2018) Electrostatic repulsion causes anticooperative DNA binding between tumor suppressor ETS transcription factors and JUN-FOS at composite DNA sites. J Biol Chem 293:18624-18635
Arbeeva, Liubov S; Hanson, Heidi A; Arbeev, Konstantin G et al. (2018) How Well Does the Family Longevity Selection Score Work: A Validation Test Using the Utah Population Database. Front Public Health 6:277
Patel, Ami B; Lange, Thoralf; Pomicter, Anthony D et al. (2018) Similar expression profiles in CD34+ cells from chronic phase chronic myeloid leukemia patients with and without deep molecular responses to nilotinib. Oncotarget 9:17889-17894
De, Shrutokirti; Van Deren, Donn; Peden, Eric et al. (2018) Two distinct ontogenies confer heterogeneity to mouse brain microglia. Development 145:

Showing the most recent 10 out of 1193 publications